Business Description
JCL Bioassay Corporation
ISIN : JP3386440006
Compare
Compare
Traded in other countries / regions
2190.Japan Description
JCL Bioassay Corporation is engaged in providing clinical and non-clinical trial services for pharmaceutical companies.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.52 | |||||
| Equity-to-Asset | 0.33 | |||||
| Debt-to-Equity | 1.29 | |||||
| Interest Coverage | 5.25 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 1.96 | |||||
| Beneish M-Score | -3.12 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.4 | |||||
| 3-Year EBITDA Growth Rate | 45.1 | |||||
| 3-Year Book Growth Rate | -3.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.77 | |||||
| Quick Ratio | 1.27 | |||||
| Days Inventory | 112.08 | |||||
| Days Sales Outstanding | 50.36 | |||||
| Days Payable | 12.03 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.7 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 26.69 | |||||
| Operating Margin % | 6.61 | |||||
| Net Margin % | 6.67 | |||||
| FCF Margin % | 4.66 | |||||
| ROE % | 15.61 | |||||
| ROA % | 4.12 | |||||
| ROIC % | 1.75 | |||||
| ROC (Joel Greenblatt) % | 17.01 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.68 | |||||
| PE Ratio without NRI | 13.68 | |||||
| PS Ratio | 0.95 | |||||
| PB Ratio | 2.09 | |||||
| Price-to-Tangible-Book | 2.16 | |||||
| Price-to-Free-Cash-Flow | 22.44 | |||||
| Price-to-Operating-Cash-Flow | 13.52 | |||||
| EV-to-EBIT | 8.83 | |||||
| EV-to-EBITDA | 8.45 | |||||
| EV-to-Revenue | 1.31 | |||||
| Price-to-Median-PS-Value | 1.4 | |||||
| Price-to-Graham-Number | 1.23 | |||||
| Earnings Yield (Greenblatt) % | 11.3 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
JCL Bioassay Corporation Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil 円) | 2,240.828 | ||
| EPS (TTM) (円) | 41.07 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (円) | 0 | ||
| 20-Day SMA (円) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (円) | 360 - 604 | ||
| Shares Outstanding (Mil) | 4.17 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
JCL Bioassay Corporation Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
JCL Bioassay Corporation Stock Events
| Event | Date | Price(円) | ||
|---|---|---|---|---|
| No Event Data | ||||
JCL Bioassay Corporation Frequently Asked Questions
What is JCL Bioassay Corporation(TSE:2190)'s stock price today?
The current price of TSE:2190 is 円562.00. The 52 week high of TSE:2190 is 円604.00 and 52 week low is 円360.00.
When is next earnings date of JCL Bioassay Corporation(TSE:2190)?
The next earnings date of JCL Bioassay Corporation(TSE:2190) is .
Does JCL Bioassay Corporation(TSE:2190) pay dividends? If so, how much?
JCL Bioassay Corporation(TSE:2190) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers